查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1588303

胃肠道诊断市场规模、份额、趋势分析报告：按测试类型、技术、应用、测试地点、区域、细分市场预测，2025-2030

Gastrointestinal Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Endoscopy, Blood Test), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

胃肠诊断市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球胃肠道诊断市场规模将达65.6亿美元，2025年至2030年复合年增长率为4.3%。

人们对胃肠道疾病的认识不断提高，胃肠道疾病检测的快速增加是推动市场的主要因素。此外，胃肠道传染病检查技术的进步预计将满足市场需求。例如，2022年5月，QIAGEN推出了QIAstat-Dx Rise，可以在一小时内提供多种疾病的结果。

久坐的生活方式、缺乏体力活动、不健康的饮食习惯和肥胖盛行率的日益增长预计将推动胃肠道诊断市场的成长。据疾病预防控制中心称，美国的肥胖率为30-40%。阿拉巴马州、阿拉斯加州和亚利桑那州等州是美国肥胖最严重的州之一，肥胖与胃食道逆流、腹泻和胃癌等胃肠道疾病有关。因此，预计将为市场成长提供动力。

与用于早期诊断和有效测试的胃肠道诊断相关的技术进步预计将在预测期内促进市场成长。例如，2022 年 3 月，Luminex Corporation 的 NxTAGxMAP GI 病原体面板获得了 CE 标誌。该测试是一项详细的多重测试，可检测粪便检体中 16 种临床最相关的病毒、寄生虫和细菌病原体的核酸。此外，该测试可以提供当天结果，并且可以一次测试 96 个检体。

此外，参与提高胃肠道疾病意识的组织的存在预计将推动市场扩张。例如，胃肠道协会（加拿大肠道研究协会）和国际胃肠道疾病基金会等组织积极参与促进胃肠道健康并增加对胃肠道疾病的了解，正在推动市场成长。

此外，市场参与者为加强产品系列和扩大全球足迹所采取的各种策略倡议可能为市场提供利润丰厚的成长机会。例如，2021 年 11 月，Liferaft Group 和 Bayer Yakuhin 宣布进行一项合作研究，以扩大胃肠道基质肿瘤患者获得基因组检测的机会。此次合作的目标是推进精准医学并改进基因检测以识别美国的患者。

此外，2021 年 6 月，普罗米修斯实验室宣布与 Multiplan 达成协议，以获得专门的胃肠道测试。 Prometheus 为改善胃肠道疾病的预后提供了突破性的检测解决方案。该协议将 Prometheus 的测试服务扩展到最大数量的客户。

胃肠诊断市场报告亮点

  • 按检查类型划分，由于对微创手术的需求不断增加，内视镜检查领域在 2024 年占据最大份额。
  • 按技术划分，PCR 由于拥有强大的产品系列和增加的产品发布，将在 2024 年占据第二位。
  • 由于胃肠道感染的高发病率和人们对胃肠道感染疾病的认识不断提高，感染疾病应用领域在2024年将占据最大份额。
  • 按测试地点划分，2024 年中心实验室部分占最大份额。预计照护现场市场将在预测期内实现最快的成长率。
  • 由于市场参与企业增加投资和研究活动活性化，预计亚太地区将在预测期内呈现最快的成长率。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章胃肠诊断市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 胃肠道诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章胃肠诊断市场：按测试类型的估计和趋势分析

  • 2024 年和 2030 年测试类型市场占有率
  • 细分仪表板
  • 按测试类型分類的全球胃肠道诊断市场前景
  • 2018-2030年市场规模、预测及趋势分析
    • 内视镜检查
    • 验血
    • 幽门螺旋桿菌检测
    • 钙卫蛋白测试
    • 免疫球蛋白A测试
    • 其他的

第五章胃肠诊断市场：技术估算与趋势分析

  • 2023年及2030年技术市场占有率
  • 细分仪表板
  • 按技术展望分類的全球胃肠诊断市场
  • 2018-2030年市场规模、预测及趋势分析
    • PCR
    • 微生物学
    • ELISA
    • 其他的

第六章胃肠诊断市场：按应用估计和趋势分析

  • 2024年及2030年应用市场占有率
  • 细分仪表板
  • 全球胃肠道诊断市场应用前景展望
  • 2018-2030年市场规模、预测及趋势分析
    • 感染
    • 发炎性肠道疾病
    • 胃食道逆流症
    • 癌症
    • 其他的

第七章胃肠诊断市场：检测地点估算及趋势分析

  • 2024 年和 2030 年检查地点市场占有率
  • 细分仪表板
  • 按测试地点分類的全球胃肠道诊断市场前景
  • 2018-2030年市场规模、预测及趋势分析
    • 中心实验室
    • 照护现场

第八章胃肠诊断市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场简介
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 2024年主要企业市场占有率分析
    • BIOMERIEUX
    • F. Hoffmann-La Roche Ltd.
    • Abbott
    • Beckman Coulter, Inc.
    • Siemens Healthineers AG
    • DiaSorin SpA
    • QIAGEN
    • Meridian Bioscience
    • Hologic, Inc.
Product Code: GVR-4-68039-988-6

Gastrointestinal Diagnostics Market Growth & Trends:

The global gastrointestinal diagnostics market size is expected to reach USD 6.56 billion by 2030, registering a CAGR of 4.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising awareness about gastrointestinal disorders and a surge in gastrointestinal disorder testing are the major factors driving the market. Moreover, technological advancements in gastrointestinal infection testing are expected to cater to the market demand. For instance, in May 2022, QIAGEN launched QIAstat-Dx Rise, which is capable of providing results in a span of one hour for multiple diseases.

The increasing trend of a sedentary lifestyle, lack of exercise, unhealthy eating habits, and a higher prevalence of obesity are anticipated to fuel GI diagnostics market growth. According to the CDC, the prevalence of obesity among people in the U.S. is between 30-40%. States such as Alabama, Alaska, and Arizona have the highest prevalence of obesity in the U.S. Obesity is associated with GI diseases such as gastroesophageal reflux disease, diarrhea, gastric cancer, and others. Hence, it is expected to impetus market growth.

Technological advancements associated with gastrointestinal diagnostics for early diagnosis and efficient testing are expected to augment market growth during the forecast period. For instance, in March 2022, Luminex Corporation obtained a CE mark for its NxTAGxMAP GI Pathogen Panel. This test is a detailed multiplex test that detects nucleic acids from the 16 most clinically relevant viral, parasitic, and bacterial pathogens in stool samples. Moreover, the test is capable of providing results on the same day and can run 96 samples at a time.

Moreover, the presence of organizations involved in increasing awareness regarding gastrointestinal disorders is expected to facilitate market expansion. For instance, organizations such as the Gastrointestinal Society (Canadian Society of Intestinal Research) and the International Foundation for Gastrointestinal Disorders are actively involved in promoting gastrointestinal health and broadening the understanding of GI disorders, thereby augmenting market growth.

Furthermore, various strategic initiatives undertaken by market players to strengthen their product portfolio and expand global footprints are likely to provide lucrative growth opportunities for the market. For instance, in November 2021, The Life Raft Group and Bayer Pharmaceuticals announced a research collaboration for broadening access to genomic testing for GI stromal tumor patients. The aim of this collaboration is to advance precision medicine and improve genetic testing to identify patients in the U.S.

In addition, in June 2021, Prometheus Laboratories, Inc. announced an agreement with MultiPlan for accessing specialized gastrointestinal testing. Prometheus offered its breakthrough testing solutions to improve the outcome of GI disorders. This agreement has allowed the testing service of Prometheus to reach the maximum number of customers.

Gastrointestinal Diagnostics Market Report Highlights:

  • On the basis of test type, the endoscopy segment held the largest share in 2024 owing to rising demand for minimally invasive procedures
  • Based on technology, the PCR accounted for the second-largest share in 2024 due to the availability of a robust product portfolio and rising product launches
  • The infection application segment held the largest share in 2024 owing to the higher incidence of GI infections and the surge in awareness
  • On the basis of test location, the central laboratories segment held the largest share in 2024. The point-of-care segment is anticipated to register the fastest growth rate throughout the forecast period
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing research activities in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test Type
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Application outlook
    • 2.2.4. Test location outlook
  • 2.3. Competitive Insights

Chapter 3. Gastrointestinal Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High prevalence of substance abuse
      • 3.2.1.2. Increase in prevalence of Gastrointestinal disorders
      • 3.2.1.3. Technological advancements pertaining to GI diagnostics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of stringent rules and regulations for GI diagnostic procedures
  • 3.3. Gastrointestinal Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Gastrointestinal Diagnostics Market: Test Type Estimates & Trend Analysis

  • 4.1. Test Type Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Gastrointestinal Diagnostics Market by Test Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Endoscopy
      • 4.4.1.1. Endoscopy market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Blood Test
      • 4.4.2.1. Blood Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. H. Pylori Test
      • 4.4.3.1. H. Pylori Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Calprotectin Test
      • 4.4.4.1. Calprotectin Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Immunoglobulin A Test
      • 4.4.5.1. Immunoglobulin A Test market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Gastrointestinal Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Technology Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Gastrointestinal Diagnostics Market by Technology Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. PCR
      • 5.4.1.1. PCR market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Microbiology
      • 5.4.2.1. Microbiology market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. ELISA
      • 5.4.3.1. ELISA market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Gastrointestinal Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Gastrointestinal Diagnostics Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Infection
      • 6.4.1.1. Infection market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Inflammatory Bowel Disease
      • 6.4.2.1. Inflammatory Bowel Disease market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Gastroesophageal Reflux Disease
      • 6.4.3.1. Gastroesophageal reflux disease market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Cancer
      • 6.4.4.1. Cancer market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Gastrointestinal Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Test Location Market Share, 2024 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Gastrointestinal Diagnostics Market by Test Location Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Central Laboratories
      • 7.4.1.1. Central Laboratories market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.2. Point-of-Care
      • 7.4.2.1. Point-of-Care market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Gastrointestinal Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. Key company market share analysis, 2024
    • 9.3.2. BIOMERIEUX
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. F. Hoffmann-La Roche Ltd.
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Abbott
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Beckman Coulter, Inc.
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Siemens Healthineers AG
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. DiaSorin S.p.A
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. QIAGEN
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Meridian Bioscience
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Hologic, Inc.
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of abbreviation
  • Table 3 North America gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 5 North America gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 North America gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 8 U.S. gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 9 U.S. gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 U.S. gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 12 Canada gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Canada gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Canada gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 16 Mexico gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Mexico gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Mexico gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 20 Europe gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 22 Europe gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Europe gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 25 Germany gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Germany gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Germany gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 29 UK gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 30 UK gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 33 France gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 34 France gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 France gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 France gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 37 Italy gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Italy gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Italy gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 41 Spain gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 42 Spain gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Spain gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 45 Denmark gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 46 Denmark gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Denmark gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 49 Sweden gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 50 Sweden gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Sweden gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 53 Norway gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 54 Norway gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Norway gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 62 China gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 63 China gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 China gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 China gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 66 Japan gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Japan gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 70 India gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 71 India gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 India gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 73 India gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 74 South Korea gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 75 South Korea gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 South Korea gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 78 Australia gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 79 Australia gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 82 Thailand gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 83 Thailand gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Thailand gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 86 Latin America gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 87 Latin America gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Latin America gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Latin America gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 90 Brazil gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 91 Brazil gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 92 Brazil gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 93 Brazil gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 94 Argentina gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 95 Argentina gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 96 Argentina gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 97 Argentina gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 98 MEA gastrointestinal diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 99 MEA gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 100 MEA gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 MEA gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 MEA gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 103 South Africa gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 104 South Africa gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 105 South Africa gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Africa gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 111 UAE gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 112 UAE gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 113 UAE gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 114 UAE gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 115 Kuwait gastrointestinal diagnostics market, by test type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait gastrointestinal diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 117 Kuwait gastrointestinal diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait gastrointestinal diagnostics market, by test location, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Gastrointestinal Diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Gastrointestinal Diagnostics market: Test Type movement analysis
  • Fig. 12 Endoscopy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Blood test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 H. pylori test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Calprotectin test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Immunoglobulin A test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Gastrointestinal Diagnostics market: Technology movement Analysis
  • Fig. 19 ELISA market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Microbiology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Gastrointestinal Diagnostics market: Application movement analysis
  • Fig. 24 Infection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Inflammatory Bowel Disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Gastroesophageal Reflux Disease (GERD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Cancer market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Gastrointestinal Diagnostics market: Test Location movement analysis
  • Fig. 30 Central laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Point-of-Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Market share of key market players- gastrointestinal diagnostics market